Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Evertz Technologies Limited (ET-T) reported revenue of $56.3-million for its first quarter ended July 31 compared to revenues of $103.4-million for the quarter ended July 31, 2019.

Net earnings were $600,000 or a penny per share compared to $13.2-million or 17 cents a year ago.

Story continues below advertisement

The expectation was for revenue of $75.9-million and earnings of 7 cents per share according to S&P Capital IQ.

**

Trillium Therapeutics Inc. (TRIL-Q; TRIL-T) announced a public offering of up to 8.5 million common shares. It intends to use the net proceeds of the offering for its “ongoing and planned clinical trials for its CD47 program, including drug supply and for working capital and general corporate purposes.”

It said Cowen and Evercore ISI are acting as joint book-running managers for the offering.

It said no common shares will be offered or sold in Canada as part of this offering.

**

Integra Resources Corp. (ITR-X) announced a $20-million bought-deal financing. It has an agreement with a syndicate of underwriters led by Raymond James Ltd. that will buy 5.9 million common shares for US$3.40 each.

Story continues below advertisement

Coeur Mining, Inc., which currently holds approximately 4.8 per cent of the issued and outstanding common shares, “has indicated an interest in purchasing as a part of the offering at the issue price a number of common shares that allows it to maintain its percentage ownership interest,” the company stated.

The company said it intends to use the net proceeds to fund exploration and pre-feasibility study expenditures at the DeLamar Project and for working capital and general corporate purposes.

**

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Follow related topics

Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies